CDKN1A and cancer: Vorinostat treatment was able to induce expression of p21WAF1/CIP1 in both SCC25 cells as well as HKs (Supplementary Figure 2C) indicating that vorinostat/LY treatment induces a cancer cell-selective inhibition of the AKT pathway.